Clovis Oncology Inc., of Boulder, Colo., said it started an underwritten public offering of shares of its common stock to raise aggregate proceeds of approximately $275 million. J.P. Morgan Securities LLC is acting as lead book-running manager and representative of the underwriters for the offering.